Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at UBS Group AG.